Puma Biotechnology Earnings Call Commercial Update Puma's Pharmacy and Distributor Network Copyright 2025 Puma Biotechnology 3 November 6, 2025 Forward-Looking Safe-Harbor Statement This presentation contains forward-looking statements, including statements regarding commercialization of NERLYNX® and the potential indications and development of our drug candidates. All forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from the anticipated res ...